US equities
|
MU
$914.58
▲+4.22%
TSLA
$396.30
▲+6.47%
NVDA
$216.25
▲+2.51%
SPCX
$148.44
▲+0.64%
META
$639.71
▼-0.45%
AAPL
$343.63
▼-1.18%
SNDK
$1,284.58
▲+3.76%
INTC
$91.92
▲+5.71%
MU
$914.58
▲+4.22%
TSLA
$396.30
▲+6.47%
NVDA
$216.25
▲+2.51%
SPCX
$148.44
▲+0.64%
META
$639.71
▼-0.45%
AAPL
$343.63
▼-1.18%
SNDK
$1,284.58
▲+3.76%
INTC
$91.92
▲+5.71%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about TRP/8803
Recent news which mentions TRP/8803
Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
November 19, 2024
Tickers
NEWS
TYPTF
Tags
Psychedelics Research
Benzinga
TRP/8803
From
Benzinga